The goal of this clinical trial is to evaluate whether cosmeceutical topical moisturizers can help with skin dryness in participants with cancer experiencing a dermatological adverse event from cancer therapies. The main question it aims to answer is: Does cosmeceutical topical moisturizers help with skin dryness? Participants will: * Visit the clinic for a baseline visit to complete skin evaluation and tests. * Apply cosmeceutical topical moisturizers daily from baseline up until the follow-up visit. * Visit the clinic for a follow-up visit (approximately 2-4 weeks from baseline) for a repeat skin evaluation and tests.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
50
Moisturizer wash applied once in the morning and once in the evening.
Moisturizer applied once in the morning and once in the evening.
Balm applied once in the morning and once in the evening.
Stanford Health Care: Supportive Dermato-Oncology Program
Palo Alto, California, United States
Change in Patient-Reported Skin Dryness Severity
Change in patient-reported skin dryness severity from baseline to follow-up visit (2-4 weeks) as measured by validated dryness severity scale (0-10 numerical rating scale where 0 = no dryness and 10 = severe dryness).
Time frame: From baseline visit to follow-up visit (approximately 2-4 weeks).
Time to improvement in dryness symptoms
The time from baseline to the first documented improvement in dryness symptoms, defined as either a ≥2-point reduction in dryness severity score from baseline or patient-reported meaningful improvement in dryness symptoms, whichever occurs first. Lower values indicate a faster improvement in symptoms.
Time frame: From baseline visit to follow-up visit (2-4 weeks).
Change in Stratum Corneum Hydration
Change in skin hydration from baseline to follow-up, measured using corneometry and reported in corneometry units (CU). Higher corneometry values indicate greater stratum corneum hydration. Positive changes from baseline reflect improved skin hydration, whereas negative changes indicate reduced hydration.
Time frame: From baseline visit to follow-up visit (2-4 weeks).
Change in Transepidermal Water Loss (TEWL)
Change in skin barrier function from baseline to follow-up, measured by transepidermal water loss (TEWL) and reported in g/h/m². TEWL quantifies the amount of water that passively evaporates through the skin. Lower TEWL values indicate improved skin barrier integrity and reduced water loss, while higher values indicate increased barrier disruption. Negative changes from baseline reflect improvement, whereas positive changes indicate worsening skin barrier function.
Time frame: From baseline visit to follow-up visit (2-4 weeks).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.